ASH Guidelines for AYA ALL: Key Recommendations and Enabling Adult Oncologists to Deliver Guideline-Concordant Care

Dr. Silverman discusses the 2026 ASH guidelines for frontline management of ALL in AYAs, asking Dr. Curran to walk through the headline recommendations and practical takeaways for adult oncologists adopting pediatric-inspired regimens. Dr. Curran affirms that the central conclusion of the guidelines, consistent with accumulating clinical data, is that pediatric-inspired regimens represent the most effective frontline approach for AYA ALL. The guidelines are meaningful both in codifying this recommendation and in raising broad awareness, particularly within adult oncology, where inclusion in NCCN guidelines has already shifted practice.

Complexities of pediatric-inspired regimens for adult oncologists include multi-agent schedules with both oral and intravenous components, medication management requiring significant patient engagement at home and in clinic, and some regimen phases requiring hospitalization. The Freyer et al. 2026 analysis found that only approximately one-third of eligible AYA patients in a real-world US claims database received guideline-concordant pediatric-inspired regimens. Dr. Curran identifies the key drivers of this gap: regimen complexity and length, the unfamiliar adverse event profile of asparaginase in the adult oncology context, and a perception that these regimens are more intensive than adult alternatives. She and Dr. Silverman agree that the intensity is different rather than greater, and that with adequate support, adult oncologists can deliver these regimens effectively.

Dr. Silverman emphasizes the importance of establishing a genuine therapeutic partnership with patients receiving pediatric-inspired regimens, ensuring they understand the rationale for each component, the importance of adherence even when treatment feels demanding, and that complexity and success are directly linked. Dr. Curran notes that the printed publication of the CALGB 10403 trial regimen can appear overwhelming to providers unfamiliar with this treatment approach, underlining the need for ongoing education and mentorship across practice settings.